Omzo vs Embody: Compounded Semaglutide Plans Compared Quickly
The Omzo vs Embody question comes down to clinician-guided, higher-touch care versus aggressively low monthly pricing and fast shipping. Early verdict: choose Omzo if you want clinician-reviewed, personalized compounded programs and are comfortable with a starting price of $179; choose Embody if your primary goal is the lowest entry price and fast 1–2 day delivery for compounded semaglutide at $69/month.
Explore Omzo clinician-guided plans
Side-by-side summary: what makes Omzo vs Embody different
This comparison focuses on the most distinctive supported differences: clinician guidance and program model, pricing and billing structure, medication type and regulatory notes, delivery speed and shipping, and extra features such as coaching or monitoring. All claims below reflect each provider’s captured statements and qualifiers.
| Criteria | Omzo | Embody |
|---|---|---|
| Primary model | Clinician-guided plans reviewed by licensed U.S. providers | Licensed provider review with telemed visits included |
| Starting price | Starting at $179 (personalized compounded semaglutide) | $69/month for compounded semaglutide (was $299) |
| Medication type | Compounded semaglutide and tirzepatide; option for prescriptions for branded meds; compounded drugs are not FDA-approved | Compounded semaglutide and tirzepatide only; compounded medications are not FDA-approved |
| Shipping speed | Fast, discreet delivery noted | Free shipping; arrives in 1–2 days after approval |
| Commitment and cancellation | Users must confirm eligibility, cost, renewal terms and state availability before enrollment | No monthly membership; cancel anytime; no long-term commitment |
Clinician guidance and program model
Omzo emphasizes clinician-guided plans reviewed by licensed U.S. providers and notes that clinical services come from third party networks of U.S.-licensed clinicians who determine eligibility and prescribe based on professional judgment. Omzo also states providers may offer compounded medication programs and may write prescriptions for branded medications, but Omzo does not sell or ship branded drugs.
Embody provides a telehealth model with prescription and telemed visits included and positions itself as a lean, prescription-forward platform. Embody frames its offering as doctor-prescribed GLP-1 treatment with licensed provider review, noting prescription and pharmacy handling occur within its process.
Cost structure and pricing transparency
Pricing is a core difference. Omzo lists personalized compounded semaglutide starting at $179 and tirzepatide starting at $279, with medication costs included in the fees collected by Omzo in the captured evidence. Omzo flags that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that results and figures do not represent guaranteed outcomes.
Embody advertises a much lower entry price of $69/month for compounded semaglutide and $119/month for tirzepatide and promotes locked flat monthly pricing, no hidden fees, and no membership. Embody also notes the $69 semaglutide pricing was cut from $299 and that final pricing may vary based on dose and clinician recommendation. Embody states the $69 pricing is a limited-time offer that may increase.
Start Embody pricing and signup
Medication type and regulatory notes
Both providers rely on compounded semaglutide and tirzepatide in their captured materials and clearly state compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo explicitly notes its compounded medications are prepared and shipped by state-licensed sterile compounding pharmacies and are not FDA-approved and that the FDA has not reviewed them. Embody likewise notes its compounded medications are not FDA-approved finished products but use the same active ingredients as some branded drugs in captured FAQ language.
Delivery speed, logistics, and commitments
Embody highlights free shipping with delivery in 1–2 days after approval and positions itself as fast and no-frills with no long-term commitment. Omzo notes fast, discreet delivery and that medication costs are included in fees collected, while advising users to confirm state availability, eligibility, and renewal terms before enrolling.
Additional features and trade-offs
Omzo focuses on a higher-touch, clinician-reviewed experience, and mentions FSA and HSA eligibility in the captured short bullets. Embody focuses on stripped-down value, rapid delivery, and cancel-anytime flexibility, and warns that its lower price point comes with fewer premium features such as integrated coaching or advanced monitoring.
Conclusion: choosing between Omzo vs Embody
Omzo vs Embody is a choice between a clinician-guided, personalized approach with Omzo and a cost-driven, fast-delivery model with Embody. Both use compounded medications and both include clinician review, but Omzo emphasizes provider networks, personalized plans, and the option for prescriptions for branded meds while Embody emphasizes $69/month pricing, free 1–2 day shipping, and no long-term commitment.
Choose Omzo if you want clinician-reviewed, personalized compounded semaglutide or tirzepatide programs and accept a starting price of $179 and the platform’s enrollment checks, eligibility confirmation, and provider discretion. Choose Embody if you prioritize the lowest listed entry price, flat locked monthly pricing at $69/month for semaglutide, fast free shipping in 1–2 days, and an uncomplicated cancel-anytime model.